Pfizer Vaccine, Election Impact & Ant Financial IPO

CNBC's Bob Pisani spoke with Nick Colas, co-founder of DataTrek Research, Matt Bartolini, Head of SPDR Americas Research at State Street Global Advisors and Brendan Ahern, CIO of KraneShares. They discussed the monster rally we’re seeing on the back of Pfizer’s vaccine news, election impact and what Ant Financial’s IPO debacle means for the Chinese ETF market. In the 'markets 102' segment, Bob discusses the strength of the rally and how sustainable the momentum is going into year-end.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.